verywellhealth3h
Doctors Can Now Prescribe Ozempic to Reduce Kidney Disease Risks in Diabetes Patients
The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.
Northern Public Radio7h
Legislators try again to create state board to review drug prices
For five years now, a bipartisan group of Illinois lawmakers have wanted to establish a Prescription Drug Affordability Board. But this year’s effort may hit the same wall as before.
brandequity.economictimes.indiatimes15h
PharmEasy: making healthcare a walk in the park, one prescription at a time
PharmEasy is redefining healthcare delivery in India. In the inaugural episode of the Masters of CX - Season 3, CEO Siddharth Shah reveals how the company leverages technology to overcome geographical ...
Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
Novo Nordisk's SWOT analysis: stock outlook amid GLP-1 market growth
A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...
McKnight's Long-Term Care News18h
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...